Key Drivers of the IBM Stock Move
- IBM stock delivered a solid Q3 earnings beat on October 22, reporting adjusted EPS of $2.65 (vs. $2.45 estimate) and revenue of $16.33B (vs. $16.09B estimate).
- Unusual options activity spiked dramatically around earnings, with over $2M in Dec 2025 $285 puts purchased on October 23, signaling hedging concerns despite raised guidance to over 5% constant currency revenue growth.
- Relative performance against the SPX500 surged from 45.2% on October 21 to 79.4% on October 22 before cooling to 74% on October 23.
International Business Machines beat both earnings and revenue estimates, lifting full-year guidance against robust AI-related demand. While reporting strength in the Infrastructure and Automation segments, the slowing cloud business segment worries resulted in mixed target revisions. The Trump administration’s reported interest in quantum computing equity stakes ironically benefited smaller rivals like IONQ, RGTI, and QBTS.
IBM Government Trades
Congressional activity shows mixed signals. Rep. Michael McCaul (R) executed multiple sales totaling $400K-$800K between June and August, while Rep. Ro Khanna (D) demonstrated a pattern of small buys and sells, most recently purchasing $1K-$15K on September 29. The trades suggest neither strong conviction nor alarm among politicians.
IBM Unusual Options
IBM’s unusual options flow was guarded pre-and post-earnings. Featured plays involve a remarkable $2M buy of October 23, Dec 2025 $285 puts, along with large November and January 2026 $285-$300 call sweeps. The prevalence of puts hints at hedging from institutions for extra insurance on the downside, considering premiums of more than $100K on more than one trade.
IBM Seasonality
Historical patterns offer little comfort for the near term. Based on data since October 2015 (11 samples), October has been IBM’s worst month, with only 36% positive periods and an average decline of 3.3%. November, however, shows promise with 70% positive periods and average gains of 4.9%, while December turns bearish again at 40% positive with a median 0.3% gain.
IBM Relative Performance
IBM’s quarterly relative strength against the SPX500 has been volatile. After plunging from 58.8 percentile in late July to just 11.4 by mid-August, the stock recovered modestly through September. The earnings announcement propelled IBM to the 79.4th percentile on October 22, meaning it outperformed nearly 80% of S&P 500 constituents, though this quickly retreated to the 74th percentile by October 23.
Analyst Focus
Wall Street remains divided. Following earnings, Bank of America raised its target from $310 to $315 (Buy), while RBC Capital lowered from $315 to $300 (Outperform), and Stifel cut from $310 to $295 (Buy). Morgan Stanley stands at $252 (Equal-Weight), with the most bearish being UBS at $210 (Sell, from $200). Consensus price target on recent estimates is approximately $295-$300, which suggests mild appreciation from current levels.
How to Track IBM Live With TrendSpider
Monitor IBM in real-time with TrendSpider’s advanced features:
- Monitor insider and congressional trading in real-time to pick up on early sentiment changes
- Compare fundamental metrics such as P/E ratio and leverage to technology sector medians
Market Update Into September 14th: Rate Hike Incoming?